Replies to post #143 on CellCyte Genetics Corp. (fka CCYG)

[ALiVE]

Our plan of operations under our Interim Operating Plan for the next 12 months is to:

(a)
perform the work specified by out Interim Operating Plan under recently executed contracts with our scientists and manufacturing consultants.
(b)
apply for State and Federal research grants to develop specific configurations and applications of the bioreactor device.


- 13 -




(c)
support the beta testing of our bioreactor product as specified in our agreements with independent research laboratories to maximize the possibility that such labs will adopt our bioreactor technology to satisfy their cell expansion needs.
(d)
continue small scale manufacturing of our cell expansion culture chambers, as needed, to maintain an adequate supply of bioreactors for the academic and institutional research organizations with which we have beta testing collaboration agreements.
(e)
locate and occupy new office, lab and manufacturing space if required to execute our Interim Operating Plan